BIOSTAR PHARMS INC by Biostar Pharmaceuticals, Inc. Financials - Benzinga

BIOSTAR PHARMS INC by Biostar Pharmaceuticals, Inc.

BSPMOTCEM

Trade with Public

Trade with Public

$1.88

At close: Sep 28, 5:00 PM EST

Overview NewsFinancialsCompare

BIOSTAR PHARMS INC by Biostar Pharmaceuticals, Inc. Financials

BIOSTAR PHARMS INC by Biostar Pharmaceuticals, Inc. (BSPM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Biostar Pharma Reports Q3 Net Loss $100K vs $1.6M In Same Qtr. Last Year

Benzinga

UPDATE: Biostar Pharma Reports Q2 EPS $(0.50) vs $(3.12) In Same Qtr. Last Year

Benzinga

Biostar Pharma Reports Q2 Net Loss $1.3M vs $6.9M In Same Qtr. Last Year

Benzinga

Biostar Pharmaceuticals Reports Q1 EPS $(0.38) vs $(0.28) In Same Qtr. Last Year, No Sales vs $801.627K YoY

Benzinga

Biostar Pharmaceuticals Reports FY16 Sales $2.4M vs $27.12M In Prior Year

Benzinga

Biostar Pharmaceuticals Reports Quarter Ended EPS $(0.71) vs. Prior Year Quarter $(0.57), Rev. $644K vs. Prior Year Quarter $4.2M

Benzinga